Dr Jaya Shrivastava
Jaya Shrivastava did her graduate and post-graduate degrees in Microbiology from India. She followed it with D.Phil at University of Oxford, UK, on Molecular Epidemiology of Schistosoma japonicum. She then did a post-doc at Cancer Research UK on identifying novel cell cycle regulators.
She is an experienced Clinical Scientist (HCPC registered- Microbiology) combining strengths in clinical diagnostics and life science research in Parasitology. She also has advanced expertise in proficiency testing, quality management, technology assessment, operational delivery and strategic decision making. Her knowledge base spans academic, clinical and public health sectors.
Dr Shrivastava currently manages ten global UK National External Quality Assessment Schemes (UK NEQAS) for Parasitology. The schemes are targeted towards blood and faecal parasites and assess microscopy, serology as well as molecular diagnostic techniques. Dr Shrivastava also contributed towards national COVID-19 incidence handling by spear heading the first UK wide COVID-19 biobank.
Dr Shrivastava is also on the ECCMID Society for Clinical Parasitology board as an elected Executive committee member. She is also associate editor for Frontiers in Parasitology. She is also member of WHO Steering committee on Malaria Nucleic Acid Amplification technology EQA scheme plus DTAG (Diagnostics Diagnostic Technical Advisory Group). She had previously served as Advisory and Evaluation Committee Team member for assessment and training in specialised Malaria diagnostic testing in the E8 region (Angola, Botswana, Mozambique, Namibia, South Africa, Swaziland, Zambia, and Zimbabwe).
She is also Honorary Associate Professor, Faculty of Infectious and Tropical Diseases at London School of Hygiene and Tropical Medicine, U. of London.
Her research interests are diagnostic and molecular epidemiology in parasitology with special interest in quality controls and laboratory accreditations.